Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.

Targeting Senescent Cells for a Healthier Aging: Challenges and Opportunities

Open access
Song, Shuling, Tchkonia, Tamara, Jiang, Jing, Kirkland, James L., Sun, Yu · 2020 · Advanced Science

Abstract

Aging is a physiological decline in both structural homeostasis and functional integrity, progressively affecting organismal health. A major hallmark of aging is the accumulation of senescent cells, which have entered a state of irreversible cell cycle arrest after experiencing inherent or environmental stresses. Although cellular senescence is essential in several physiological events, it plays a detrimental role in a large array of age‐related pathologies. Recent biomedical advances in specifically targeting senescent cells to improve healthy aging, or alternatively, postpone natural aging and age‐related diseases, a strategy termed senotherapy, have attracted substantial interest in both scientific and medical communities. Challenges for aging research are highlighted and potential avenues that can be leveraged for therapeutic interventions to control aging and age‐related disorders in the current era of precision medicine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/advs.202002611

Cites

163 of 163 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The canonical hallmarks of aging, its accompanying chronic diseases and potential interventions. Aging is characterized by a set of typical hallmarks, including genomic instability, epigenetic alterations, mitochondrial dysfunction, loss of proteostasis, telomere attrition, deregulated nutrient sensing, stem cell exhaustion, and cellular senescence. During natural aging, the incidence of age‐related pathologies increases in a progressive manner, most of which implicate cellular senescence. Therapeutic avenues involving genetic, dietary, or pharmacologic approaches have emerged as potent intervention strategies to prevent or ameliorate aging symptoms, although with different mechanisms. Given that the aged population in a global range is drastically increasing and that aging outstands as the greatest risk factor for the vast majority of chronic diseases responsible for both morbidity and mortality, it is critical, urgent and sagacious to expand geroscience aimed at improving human healthspan. Note, the course of organismal aging is indeed accompanied by various natural activities such as revolution of planets in the universal setting, day and night (exemplified as symbols at the corners of the circle). Part of the figure (mainly the circle) is adapted with permission.[ 164 ] Copyright year 2020, CellPress.
Figure 1 The canonical hallmarks of aging, its accompanying chronic diseases and potential interventions. Aging is characterized by a set of typical hallmarks, including genomic instability, epigenetic alterations, mitochondrial dysfunction, loss of proteostasis, telomere attrition, deregulated nutrient sensing, stem cell exhaustion, and cellular senescence. During natural aging, the incidence of age‐related pathologies increases in a progressive manner, most of which implicate cellular senescence. Therapeutic avenues involving genetic, dietary, or pharmacologic approaches have emerged as potent intervention strategies to prevent or ameliorate aging symptoms, although with different mechanisms. Given that the aged population in a global range is drastically increasing and that aging outstands as the greatest risk factor for the vast majority of chronic diseases responsible for both morbidity and mortality, it is critical, urgent and sagacious to expand geroscience aimed at improving human healthspan. Note, the course of organismal aging is indeed accompanied by various natural activities such as revolution of planets in the universal setting, day and night (exemplified as symbols at the corners of the circle). Part of the figure (mainly the circle) is adapted with permission.[ 164 ] Copyright year 2020, CellPress.CC BY · PubMed Central
Figure 2 Emerging strategies that showed efficacy in targeting cellular senescence. At late or advanced stages of life, senescent cells progressively accumulate in multiple tissue types and substantially promote the development of multiple age‐related diseases. Increasing lines of studies suggest that targeting specific fundamental mechanisms of aging may be more effective than treating each chronic pathology individually to restrain the impacts of aging on healthspan and lifespan. Pilot trials have been initiated to therapeutically target cellular senescence, such as A) selectively removing senescent cells via induction of their death (senolytic treatment), and B) engagement of the immune surveillance (senescence‐directed immunotherapy), with the potential of each strategy in depleting senescent cells from tissue microenvironment demonstrated by recent investigations. In each mechanistic illustration, yellow arrows mean stimulating or promotive actions, while red arrows represent suppressive or counteractive functions. A) Agents within yellow rectangles are example senolytics. B) Scissors represent shedding of NKG2D ligands by MMPs secreted by senescent cells, especially those induced by oncogene activation. (A) adapted with permission.[ 164 ] Copyright year 2020, CellPress. We stated “Figure (A) adapted with permission [164]. Copyright year 2020, CellPress.” Please refer to Page 33 (Figure legend, Figure 2).
Figure 2 Emerging strategies that showed efficacy in targeting cellular senescence. At late or advanced stages of life, senescent cells progressively accumulate in multiple tissue types and substantially promote the development of multiple age‐related diseases. Increasing lines of studies suggest that targeting specific fundamental mechanisms of aging may be more effective than treating each chronic pathology individually to restrain the impacts of aging on healthspan and lifespan. Pilot trials have been initiated to therapeutically target cellular senescence, such as A) selectively removing senescent cells via induction of their death (senolytic treatment), and B) engagement of the immune surveillance (senescence‐directed immunotherapy), with the potential of each strategy in depleting senescent cells from tissue microenvironment demonstrated by recent investigations. In each mechanistic illustration, yellow arrows mean stimulating or promotive actions, while red arrows represent suppressive or counteractive functions. A) Agents within yellow rectangles are example senolytics. B) Scissors represent shedding of NKG2D ligands by MMPs secreted by senescent cells, especially those induced by oncogene activation. (A) adapted with permission.[ 164 ] Copyright year 2020, CellPress. We stated “Figure (A) adapted with permission [164]. Copyright year 2020, CellPress.” Please refer to Page 33 (Figure legend, Figure 2).CC BY · PubMed Central
Figure 3 A hypothetic model to illustrate senotherapy‐mediated healthy aging. The first stage of the survival curve refers to the pre‐mortality plateau phase (PPP), during which ≈10% of the overall population is lost over a relatively long period. Alternatively referred to as a healthy lifespan, the PPP covers three sub‐stages, including an adolescent period when the body actively develops, a young adult period when the individual is physiologically mature, and a middle‐aged period when the mortality rate begins to increase. During the overall PPP span, 90% of the population remains alive, after which the mortality rate significantly arises and the population declines rapidly, a period constituting the late‐aged phase. However, in the case of senotherapy which theoretically comprises multiple waves of medications with senolytics administered in an intermittent or metronomic manner, the lifespan can be remarkably extended. Senotherapy can eliminate senescent cells, promote tissue repair, improve organ regeneration, and ameliorate multiple age‐related pathologies, thus providing a prominent avenue for a healthier aging of human populations.[ 165 , 166 ]
Figure 3 A hypothetic model to illustrate senotherapy‐mediated healthy aging. The first stage of the survival curve refers to the pre‐mortality plateau phase (PPP), during which ≈10% of the overall population is lost over a relatively long period. Alternatively referred to as a healthy lifespan, the PPP covers three sub‐stages, including an adolescent period when the body actively develops, a young adult period when the individual is physiologically mature, and a middle‐aged period when the mortality rate begins to increase. During the overall PPP span, 90% of the population remains alive, after which the mortality rate significantly arises and the population declines rapidly, a period constituting the late‐aged phase. However, in the case of senotherapy which theoretically comprises multiple waves of medications with senolytics administered in an intermittent or metronomic manner, the lifespan can be remarkably extended. Senotherapy can eliminate senescent cells, promote tissue repair, improve organ regeneration, and ameliorate multiple age‐related pathologies, thus providing a prominent avenue for a healthier aging of human populations.[ 165 , 166 ]CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 162 references

Research works printed but not linked: 6

  1. 10.1016/j.cell.2008.06.049 · doi:10.1016/j.cell.2008.06.049 · Paper page
  2. Chen C.‐L., 2018, Int. J. Mol. Sci., 38, 16
  3. Kang C., 2019, Mol. Cells, 42, 821
  4. 10.1038/onc.2015.494 · DOI
  5. 10.1038/s41467-019-12888-x · DOI · Paper page
  6. 10.18632/aging.101787 · DOI · Paper page

Cited by

See all 129

Metadata

Authors
Song, S., Tchkonia, T., Jiang, J., Kirkland, J. L., & Sun, Y.
Affiliations
  • Binzhou Medical University (CN)
  • Robert and Arlene Kogod Center on Aging Mayo Clinic Rochester MN 55905 USA
  • Mayo Clinic (US)
Corresponding author
Sun, Yu
Venue
Advanced Science
Publisher
Wiley
Published
2020-10-19
Volume
7
Issue
23
Pages
2002611-2002611
ISSN
2198-3844 (ISSN-L)
OpenAlex
W3093572772
Cited by
129
References
162
Citations by year
2026: 10 · 2025: 20 · 2024: 23 · 2023: 40 · 2022: 23 · 2021: 12 · 2020: 1
FWCI
2.42
Type
journal article
Language
en
Open access
Locations
  • Advanced Science (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Key Research and Development Program of China (2016YFC1302400, 2019YFC2002801)
  • National Natural Science Foundation of China (81472709, 31671425, 31871380)
  • Science and Technology Commission of Shanghai Municipality (20XD1404300)
  • U.S. Department of Defense (PC111703)
  • National Institutes of Health (R37‐AG013925, P01 AG062413)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
Keywords
cellular senescence, senolytics, senotherapy, healthy aging, age-related diseases, cell cycle arrest, senolytic therapy, precision medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting Senescent Cells for a Healthier Aging: Challenges and Opportunities. https://app.cochat.ai/papers/10.1002/advs.202002611
The paper
Song, S., Tchkonia, T., Jiang, J., Kirkland, J. L., & Sun, Y. (2020). Targeting Senescent Cells for a Healthier Aging: Challenges and Opportunities. Advanced Science. https://doi.org/10.1002/advs.202002611

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.